Penicillamine - Rheumatoid arthritis
You are here : Home > Formulary Search > Penicillamine - Rheumatoid arthritis
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Status 1
Red
Formulations :
- Tablets
Formulary Status :
Associated Icons :
Restrictions / Comments :
Documentation
Guidelines (National)
Evidence Review
PAD Profile
ChemicalSubstance :
Penicillamine
Indication :
Rheumatoid arthritis
Group Name :
Keywords :
Shared Care
Brand Names Include :
Distamine
Important Information :
Severe disease only
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
2
Other Indications
Below are listed other indications that Penicillamine is used to treat.
Other Drugs
Below are listed other drugs that are used to treat Rheumatoid arthritis.
Committee Recommendations (1)
The Prescribing Clinical Network considers the prescribing of penicillamine in rheumatoid arthritis in NEW patients to be RED – specialist ONLY drugs - treatment initiated and continued by specialist clinicians.
Please note:
- Penicillamine is no longer used routinely (see guidelines from BSR and BHPR below).
- For any new patients initiated on penicillamine, prescribing should be retained by the specialist.
- For the small number of patients currently taking penicillamine in primary care, monitoring requirements should be as described in the current BNF and SPC.
Primary care monitoring requirements for people on penicillamine are available from CKS at: https://cks.nice.org.uk/dmards#!scenario:12